Showing results (71-80 of 117) with videos related to
Sort By:
Pageof 12
Neurotoxicology|December 18, 2020
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J miceGiulia Costa, Stefan Spulber, Elena Paci, et al.European Journal of Pharmacology|July 26, 2017
A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's diseaseWai Kin D Ko, Qin Li, Long Yun Cheng, et al.Experimental Brain Research|November 9, 2007
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male ratsNicola Simola, Diego Bustamante, Annalisa Pinna, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2018
6-n-propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's diseaseGiovanni Cossu, Melania Melis, Marianna Sarchioto, et al.International Journal of Molecular Sciences|June 2, 2021
Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's DiseaseMarcello Serra, Annalisa Pinna, Giulia Costa, et al.Journal of Neurochemistry|October 13, 2009
Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's diseaseAnna R Carta, Anil Kachroo, Nicoletta Schintu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 11, 2023
Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in miceGiulia Costa, Marcello Serra, Riccardo Maccioni, et al.Neuropharmacology|December 3, 2009
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drugAnnalisa Pinna, Elisabetta Tronci, Nicoletta Schintu, et al.Experimental Neurology|November 5, 2024
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's DiseaseMarcello Serra, Gaia Faustini, Viviana Brembati, et al.Iscience|October 24, 2022
D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesiaErmanno Florio, Marcello Serra, Robert G Lewis, et al.Pageof 12